U.S. FDA authorizes emergency use of experimental antibody drug Trump took

U.S. FDA authorizes emergency use of experimental antibody drug Trump took

U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that U.S. President Donald Trump was given when he was sickened last month.

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

Read more: Regeneron: What we know about the experimental coronavirus drug Trump took

The drug is given as a one-time treatment through an IV. The FDA allowed its use in adults and children 12 and over who weigh at least 88 pounds (40 kilograms) and who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

Story continues below advertisement

Emergency authorization allows use of the drug to start while studies are continuing to establish safety and effectiveness. Early results suggest the drug may reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression, the FDA said.

Regeneron said that initial doses will be made available to roughly 300,000 patients through a federal government allocation program. Patients will not be charged for the drug but may have to pay part of the cost of giving the IV.

4:53 Coronavirus: Trump says COVID-19 was ‘blessing from God’, promises to speed approval of medications
Coronavirus: Trump says COVID-19 was ‘blessing from God’, promises to speed approval of medications – Oct 7, 2020

Initial supplies will likely be vastly outstripped by demand as the U.S.…

Want to know more click here go to health news source.



Follow us get Health Tips Update
Close

Health Tips Language